Single Ascending Dose Safety, Tolerability and Pharmacokinetics Study of GLYX-13 in Normal Volunteers

NCT01014650 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: GLYX-13
DRUG: IV normal saline

Sponsor

Naurex, Inc, an affiliate of Allergan plc